carbostyril has been researched along with Urinary Bladder Neoplasms in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, W; Hong, JH; Jeong, BC; Jeong, DE; Jo, A; Joo, KM; Lee, HO; Lee, HW; Lim, JE; Nam, DH; Park, SH; Park, WY | 1 |
| Di Fazio, P; Hänze, J; Hegele, A; Hofmann, R; Kessel, F | 1 |
| Hänze, J; Hegele, A; Henrici, M; Hofmann, R; Olbert, PJ | 1 |
| Galsky, MD; Gimpel-Tetra, K; Godbold, J; Holcombe, RF; Lee, KM; Lowe, N; Misiukiewicz, K; Oh, WK; Posner, M; Soto, R; Tsao, CK | 1 |
| Billia, M; Chin, J; Mazzola, CR; Siddiqui, KM | 1 |
| Chester, JD; Cooper, PA; Knowles, MA; Lamont, FR; Shnyder, SD; Tomlinson, DC | 1 |
| Chung, JG; Hsu, SC; Huang, CC; Kuo, JH; Kuo, SC; Lai, KC; Lin, JJ; Wu, SH; Yang, JS; Yang, ST; Yu, CC | 1 |
| Böhle, A; Fornara, P; Jocham, D; Jurczok, A; Zacharias, M | 1 |
| Mardiak, J; Moore, M; Palmer, PA; Perez-Ruixo, JJ; Rosenberg, JE; Sahasrabudhe, D; Seigne, JD; Small, EJ; Vaughn, DJ; von der Maase, H | 1 |
1 review(s) available for carbostyril and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Dovitinib: rationale, preclinical and early clinical data in urothelial carcinoma of the bladder.
Topics: Animals; Antineoplastic Agents; Benzimidazoles; Carcinoma, Transitional Cell; Disease Progression; Humans; Molecular Targeted Therapy; Quinolones; Receptor, Fibroblast Growth Factor, Type 3; Urinary Bladder Neoplasms | 2014 |
3 trial(s) available for carbostyril and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Single-cell RNA sequencing reveals the tumor microenvironment and facilitates strategic choices to circumvent treatment failure in a chemorefractory bladder cancer patient.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Drug Resistance, Neoplasm; Humans; Male; Mice; Middle Aged; Proto-Oncogene Proteins p21(ras); Quinolones; RNA-Seq; Single-Cell Analysis; Transcriptome; Treatment Failure; Tumor Microenvironment; Urinary Bladder Neoplasms | 2020 |
Phase Ib study of dovitinib in combination with gemcitabine plus cisplatin or gemcitabine plus carboplatin in patients with advanced solid tumors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carboplatin; Cisplatin; Colonic Neoplasms; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Quinolones; Thromboembolism; Treatment Outcome; Urinary Bladder Neoplasms; Young Adult | 2014 |
A phase II trial of R115777, an oral farnesyl transferase inhibitor, in patients with advanced urothelial tract transitional cell carcinoma.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Transitional Cell; Diarrhea; Enzyme Inhibitors; Exanthema; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Quinolones; Remission Induction; Urinary Bladder Neoplasms; Urologic Neoplasms; Urothelium | 2005 |
5 other study(ies) available for carbostyril and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Effects of multi and selective targeted tyrosine kinase inhibitors on function and signaling of different bladder cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Benzimidazoles; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cluster Analysis; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Gene Expression Profiling; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Mitogen-Activated Protein Kinases; Molecular Targeted Therapy; Phenylurea Compounds; Principal Component Analysis; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Quinolones; Signal Transduction; Time Factors; Transcriptome; Urinary Bladder Neoplasms | 2018 |
Epithelial mesenchymal transition status is associated with anti-cancer responses towards receptor tyrosine-kinase inhibition by dovitinib in human bladder cancer cells.
Topics: Antigens, CD; Antineoplastic Agents; Benzimidazoles; Cadherins; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Epithelial-Mesenchymal Transition; Gene Expression; Humans; Inhibitory Concentration 50; Quinolones; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 3; Signal Transduction; Urinary Bladder Neoplasms; Vimentin | 2013 |
Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo.
Topics: Animals; Apoptosis; Benzimidazoles; Blotting, Western; Carcinoma, Transitional Cell; Cell Cycle; Cell Proliferation; Cells, Cultured; Humans; Immunoenzyme Techniques; In Vitro Techniques; Male; Mice; Mice, Inbred BALB C; Mutation; Phosphorylation; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Quinolones; Receptor, Fibroblast Growth Factor, Type 1; Receptor, Fibroblast Growth Factor, Type 3; Urinary Bladder Neoplasms; Urothelium; Xenograft Model Antitumor Assays | 2011 |
A novel synthetic 2-(3-methoxyphenyl)-6,7-methylenedioxoquinolin-4-one arrests the G2/M phase arrest via Cdc25c and induces apoptosis through caspase- and mitochondria-dependent pathways in TSGH8301 human bladder cancer cells.
Topics: Apoptosis; Apoptosis Inducing Factor; bcl-2-Associated X Protein; Benzodioxoles; Caspases; cdc25 Phosphatases; Cell Cycle Checkpoints; Cell Division; Cell Line, Tumor; Checkpoint Kinase 1; Checkpoint Kinase 2; Cytochromes c; DNA Damage; DNA Fragmentation; G2 Phase; Humans; Membrane Potential, Mitochondrial; Mitochondria; Protein Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-bcl-2; Quinolones; Reactive Oxygen Species; Signal Transduction; Urinary Bladder Neoplasms | 2012 |
[Experimental investigations of the optimal therapy of systemic BCG infection in vivo].
Topics: Adrenal Cortex Hormones; Aged; Animals; Anti-Bacterial Agents; Antitubercular Agents; BCG Vaccine; Data Interpretation, Statistical; Disease Models, Animal; Female; Humans; Hypersensitivity; Immunotherapy; Male; Mice; Mice, Inbred C57BL; Mycobacterium bovis; Quinolones; Time Factors; Tuberculosis; Tumor Cells, Cultured; Urinary Bladder; Urinary Bladder Neoplasms | 2004 |